Study presents new persistence analysis of FINTEPLA, evaluating the efficacy and tolerability of FINTEPLA over a span of 12 months1 Real-world data looks into the need for resources to support caregivers – both parents and siblings – of people living with developmental and epileptic encephalopathies such as Dravet and Lennox-Gastaut syndromes in the transition from […]

Related Keywords

Florida , United States , Brussels , Bruxelles Capitale , Belgium , Smyrna , Izmir , Turkey , Orlando , American , Becky Malone , Lauried Bailey , Tom Stanton , Brad Chapman , Antje Witte , Rare Epilepsy Parents , A Survey Of Rare Epilepsy Parents , Program See Boxed Warning , Guideline Development , Twitter , Group Of Companies , Epilepsy Foundation , Corporate Communications , Child Neurology Foundation , Bull World Health Organ , Ucb Inc , American Epilepsy Society Annual Meeting , Danny Did Foundation , American Epilepsy Society , Annual Meeting , Rare Syndromes , Month Persistence Analysis , Dravet Syndrome , Komodo Healthcare , Adult Siblings , Prepare Families Living , Long Term Adult Care Planning , Their Loved , Gap Between Neurologists , Systematic Literature Review , Heart Disease , Pulmonary Arterial Hypertension , Boxed Warning , Mitigation Strategy , Decreased Weight , Antiepileptic Drugs , Blood Pressure , Prescribing Information , Medication Guide , Important Safety Information , Euronext Brussels , Epileptic Encephalopathy , Accessed November , Epilepsy Behav , Implementation Subcommittee , American Academy , American Epilepsy , World Health , Who Can Get ,